Changed epidemiology of influenza and RSV hospitalizations after the emergence of SARS-CoV-2 in Norway, 2017 - 2024
Preprint
Abstract
Background Many countries reported missing and atypical influenza and RSV seasons during the COVID-19 pandemic. Here we describe the incidence and seasonality of COVID-19, influenza, and RSV hospitalizations in Norway between 2017-2024, and the disease burden between 2022-2024. Methods Using nationwide data on ICD-10 discharge codes, procedure codes and laboratory results, we calculate the incidence of COVID-19, influenza, and RSV hospitalizations, by age group, week and season between January 2017 to April 2024, and report proportions receiving intensive care, proportion of deaths and length of stay between 2022-2024. Results The transmission of influenza and RSV was interrupted the first year of the COVID-19 pandemic and reemerged with epidemics outside of the normal seasonality in 2021/2022, after COVID-19 restrictions were removed. Between 2022-2024, COVID-19 was a greater contributor to hospitalizations than influenza and RSV, with higher mortality rate within two weeks of admission. The use of ventilatory support/intensive care admission was highest among patients hospitalized with RSV. Conclusion The transmission of influenza and RSV was interrupted during the first year of the COVID-19 pandemic, followed by an unusual seasonality. Although many hospitalizations are caused by RSV and influenza, COVID-19 was the largest contributor of these three to hospital burden in the first years with co-circulation.Keywords
All Related Versions
- Published version: Annals of Epidemiology, 108, 77.
This publication has 23 references indexed in Scilit:
- RSV healthcare burden in adults before and since the emergence of the COVID-19 pandemic in 6 European countriesmedRxiv, 2024
- Comparison of mortality and outcomes of four respiratory viruses in the intensive care unit: a multicenter retrospective studyScientific Reports, 2024
- Comparison of COVID-19 with influenza A in the ICU: a territory-wide, retrospective, propensity matched cohort on mortality and length of stayBMJ Open, 2023
- Outcomes of influenza and COVID-19 inpatients in different phases of the SARS-CoV-2 pandemic: a single-centre retrospective case–control studyJournal of Hospital Infection, 2023
- Estimation of the number of RSV-associated hospitalisations in adults in the European UnionmedRxiv, 2023
- Comparison of Clinical Profiles and Mortality Outcomes Between Influenza and COVID-19 Patients Invasively Ventilated in the ICU: A Retrospective Study From All Paris Public Hospitals From 2016 to 2021Critical Care Explorations, 2022
- Determinants of RSV epidemiology following suppression through pandemic contact restrictionsEpidemics, 2022
- A country-level analysis comparing hospital capacity and utilisation during the first COVID-19 wave across EuropeHealth Policy, 2021
- The COVID-19 pandemic in Norway: The dominance of social implications in framing the policy responseHealth Policy and Technology, 2020
- Burden of medically attended influenza in Norway 2008‐2017Influenza and Other Respiratory Viruses, 2019